Completed PHASE2 INTERVENTIONAL NCT00103363

Sputum Cytology in Screening Heavy Smokers For Lung Cancer

Lung Cancer Screening and Tissue Procurement

Sponsor: National Cancer Institute (NCI)

Interventions annual screening cytology specimen collection procedure physiologic testing study of high risk factors

Updated 5 times since 2017 Last updated: May 5, 2014 Started: Feb 28, 1993 Primary completion: Feb 28, 1994 Completion: Feb 28, 1994

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Lung Cancer, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 5 data snapshots since 1993. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Feb 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
University of Colorado, Denver

Data source: University of Colorado, Denver

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Denver, United States